CARDIOR PHARMACEUTICALS
Cardior Pharmaceuticals is a biotechnology company that engages in the development of non-coding RNA based therapeutics for the treatment and prevention of heart disease. It focuses on developing CDR-132X, an oligonucleotide-based inhibitor of a molecular master switch (microRNA) controlling pathological alterations of the heart following stress or injury. Cardior Pharmaceuticals is a planned academic spin-off developing new therapeutics for the treatment and prevention of heart disease - the number one cause of death in the western world.
CARDIOR PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2016-01-01
Address:
Hanover, Niedersachsen, Germany
Country:
Germany
Website Url:
http://www.cardior.de
Total Employee:
11+
Status:
Active
Contact:
+49 (0)511-33 85 99 30
Email Addresses:
[email protected]
Total Funding:
80.01 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Nginx Sitelinks Search Box Yoast WordPress SEO Plugin Yoast SEO Premium
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Current Advisors List
Current Employees Featured
Founder
Investors List
BioMedPartners
BioMedPartners investment in Series B - Cardior Pharmaceuticals
Inkef
Inkef investment in Series B - Cardior Pharmaceuticals
Life Sciences Partners
Life Sciences Partners investment in Series B - Cardior Pharmaceuticals
Sunstone Partners
Sunstone Partners investment in Series B - Cardior Pharmaceuticals
Hadean Ventures
Hadean Ventures investment in Series B - Cardior Pharmaceuticals
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Series B - Cardior Pharmaceuticals
Fund+
Fund+ investment in Series B - Cardior Pharmaceuticals
Bristol Myers Squibb
Bristol Myers Squibb investment in Series B - Cardior Pharmaceuticals
coparion
coparion investment in Series B - Cardior Pharmaceuticals
European regional development fund (ERDF)
European regional development fund (ERDF) investment in Grant - Cardior Pharmaceuticals
Official Site Inspections
http://www.cardior.de
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
